NCT07246993 Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
| NCT ID | NCT07246993 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Persistent Post Concussion Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-03-05 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-03-05 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).
Eligibility Criteria
Inclusion Criteria: * Age 18-65 * Has sustained a single mTBI 3-12 months prior to enrollment * Meets criteria for PPCS (assessed using the CP Screen) * Has reliable access to a smartphone Exclusion Criteria: * Inability to provide informed consent or complete study procedures * History of moderate/severe TBI * Significant neurological or psychiatric disorders (other than PPCS-related symptoms like mild depression/anxiety) * Substance dependence within the last six months * Contraindications to tDCS (e.g., implanted metal, skin lesions on scalp)
Contact & Investigator
Jazmin Camchong, PhD
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT07246993 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Persistent Post Concussion Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07246993 currently recruiting?
Yes, NCT07246993 is actively recruiting participants. Contact the research team at stima011@umn.edu for enrollment information.
Where is the NCT07246993 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07246993 clinical trial?
NCT07246993 is sponsored by University of Minnesota. The principal investigator is Jazmin Camchong, PhD at University of Minnesota. The trial plans to enroll 30 participants.